EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 424 filers reported holding EXELIXIS INC in Q4 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $340,714,093 | +94974.9% | 15,163,066 | +0.4% | 0.58% | +2.7% |
Q1 2024 | $358,364 | -4.3% | 15,101,716 | -3.3% | 0.56% | -2.9% |
Q4 2023 | $374,621 | +12.7% | 15,615,716 | +2.6% | 0.58% | +2.3% |
Q3 2023 | $332,490 | +18.8% | 15,216,916 | +3.9% | 0.57% | +40.7% |
Q2 2023 | $279,915 | -5.6% | 14,647,589 | -4.1% | 0.40% | +2.3% |
Q1 2023 | $296,573 | +23.6% | 15,279,389 | +2.1% | 0.39% | +20.1% |
Q4 2022 | $239,976 | -99.9% | 14,961,089 | -6.7% | 0.33% | -7.9% |
Q3 2022 | $251,364,000 | -32.1% | 16,030,844 | -9.9% | 0.36% | -18.7% |
Q2 2022 | $370,262,000 | -3.1% | 17,783,937 | +5.5% | 0.44% | -2.4% |
Q1 2022 | $382,268,000 | +22.3% | 16,862,278 | -1.4% | 0.45% | +15.4% |
Q4 2021 | $312,602,000 | -15.7% | 17,100,778 | -2.5% | 0.39% | -18.8% |
Q3 2021 | $370,954,000 | +12.6% | 17,547,501 | -3.0% | 0.48% | +16.5% |
Q2 2021 | $329,463,000 | -21.7% | 18,082,501 | -3.0% | 0.41% | -21.6% |
Q1 2021 | $420,915,000 | -3.3% | 18,632,801 | -14.1% | 0.52% | +10.8% |
Q4 2020 | $435,171,000 | -21.5% | 21,682,651 | -4.3% | 0.47% | -14.5% |
Q3 2020 | $554,174,000 | +1.5% | 22,665,610 | -1.5% | 0.55% | +17.4% |
Q2 2020 | $546,184,000 | +58.0% | 23,006,910 | +14.6% | 0.47% | +40.2% |
Q1 2020 | $345,624,000 | +9.3% | 20,071,060 | +11.8% | 0.34% | +38.3% |
Q4 2019 | $316,348,000 | +20.5% | 17,953,926 | +20.9% | 0.24% | +9.5% |
Q3 2019 | $262,615,000 | -8.7% | 14,849,596 | +10.4% | 0.22% | -12.3% |
Q2 2019 | $287,522,000 | +26.3% | 13,454,473 | +40.7% | 0.25% | +22.2% |
Q1 2019 | $227,653,000 | +95.5% | 9,565,273 | +61.6% | 0.21% | +63.0% |
Q4 2018 | $116,441,000 | +60.3% | 5,919,727 | +44.4% | 0.13% | +69.3% |
Q3 2018 | $72,629,000 | -53.7% | 4,098,710 | -43.0% | 0.08% | -12.8% |
Q2 2018 | $156,729,000 | +124.4% | 7,190,620 | +128.1% | 0.09% | +13.2% |
Q1 2018 | $69,835,000 | -25.5% | 3,152,810 | +2.3% | 0.08% | -26.2% |
Q4 2017 | $93,692,000 | +1.8% | 3,081,960 | -18.9% | 0.10% | -4.6% |
Q3 2017 | $92,042,000 | +53.2% | 3,798,660 | +55.7% | 0.11% | +40.3% |
Q2 2017 | $60,075,000 | +77.9% | 2,439,110 | +56.5% | 0.08% | +63.8% |
Q1 2017 | $33,763,000 | +72.8% | 1,558,060 | +18.9% | 0.05% | +51.6% |
Q4 2016 | $19,540,000 | -18.2% | 1,310,510 | -29.9% | 0.03% | -26.2% |
Q3 2016 | $23,897,000 | +492.1% | 1,868,450 | +85.2% | 0.04% | +425.0% |
Q1 2016 | $4,036,000 | +29.8% | 1,008,919 | +83.0% | 0.01% | +14.3% |
Q4 2015 | $3,110,000 | +1114.8% | 551,350 | +209.7% | 0.01% | +600.0% |
Q4 2014 | $256,000 | -95.4% | 178,033 | -89.3% | 0.00% | -92.3% |
Q2 2014 | $5,621,000 | – | 1,658,150 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |